$ADTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aditx Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aditx Therapeutics, Inc.. Get notifications about new insider transactions in Aditx Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | ADTX | Aditx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 75,000 | 0 | 826,620 | 751.6 K to 826.6 K (+9.98 %) |
| Jun 08 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Grant | A | 0.00 | 75,000 | 0 | 826,620 | 751.6 K to 826.6 K (+9.98 %) |
| Jun 02 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | P | 2.89 | 100 | 289 | 751,620 | 751.5 K to 751.6 K (+0.01 %) |
| Jun 02 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | P | 2.90 | 800 | 2,320 | 751,520 | 750.7 K to 751.5 K (+0.11 %) |
| Jun 02 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | P | 2.95 | 1,000 | 2,950 | 750,720 | 749.7 K to 750.7 K (+0.13 %) |
| Jun 02 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | P | 2.95 | 1,000 | 2,950 | 749,720 | 748.7 K to 749.7 K (+0.13 %) |
| Jun 02 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | P | 2.93 | 500 | 1,465 | 748,720 | 748.2 K to 748.7 K (+0.07 %) |
| May 25 2021 | ADTX | Aditx Therapeutics ... | Pankovcin Corinne | CHIEF FINANCIAL OFF ... | Buy | P | 2.56 | 4,220 | 10,803 | 114,220 | 110 K to 114.2 K (+3.84 %) |
| Mar 22 2021 | ADTX | Aditx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Option Exercise | O | 4.00 | 18,750 | 75,000 | 0 | |
| Mar 22 2021 | ADTX | Aditx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Buy | O | 4.00 | 18,750 | 75,000 | 1,015,006 | 996.3 K to 1 M (+1.88 %) |
| Mar 01 2021 | ADTX | Aditx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Grant | A | 0.00 | 225,000 | 0 | 772,220 | 547.2 K to 772.2 K (+41.12 %) |
| Nov 04 2020 | ADTX | ADiTx Therapeutics ... | Pankovcin Corinne | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.92 | 165,000 | 316,800 | 165,000 | |
| Nov 04 2020 | ADTX | ADiTx Therapeutics ... | Pankovcin Corinne | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.92 | 15,000 | 28,800 | 15,000 | |
| Nov 04 2020 | ADTX | ADiTx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Option Exercise | A | 1.92 | 110,000 | 211,200 | 110,000 | |
| Nov 04 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Option Exercise | A | 1.92 | 100,000 | 192,000 | 100,000 | |
| Nov 04 2020 | ADTX | ADiTx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.92 | 100,000 | 192,000 | 100,000 | |
| Oct 15 2020 | ADTX | ADiTx Therapeutics ... | ANTHONY LAURA E | Director | Option Exercise | D | 1.94 | 10,000 | 19,400 | 10,000 | |
| Oct 15 2020 | ADTX | ADiTx Therapeutics ... | Brady Brian Michael | Director | Option Exercise | D | 1.94 | 10,000 | 19,400 | 10,000 | |
| Aug 03 2020 | ADTX | ADiTx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Option Exercise | X | 0.00 | 47,222 | 0 | 0 | |
| Aug 03 2020 | ADTX | ADiTx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Option Exercise | X | 0.00 | 47,222 | 0 | 0 | |
| Aug 03 2020 | ADTX | ADiTx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Buy | X | 11.25 | 47,222 | 531,248 | 996,256 | 949 K to 996.3 K (+4.98 %) |
| Aug 03 2020 | ADTX | ADiTx Therapeutics ... | Shabahang Shahrokh | CHIEF INNOVATION OF ... | Buy | X | 11.25 | 47,222 | 531,248 | 996,256 | 949 K to 996.3 K (+4.98 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Option Exercise | X | 0.00 | 38,055 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Option Exercise | X | 0.00 | 35,555 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Option Exercise | X | 0.00 | 38,055 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | X | 11.25 | 38,055 | 428,119 | 476,110 | 438.1 K to 476.1 K (+8.69 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Option Exercise | X | 0.00 | 35,555 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | X | 11.25 | 35,555 | 399,994 | 71,110 | 35.6 K to 71.1 K (+100.00 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | X | 11.25 | 38,055 | 428,119 | 476,110 | 438.1 K to 476.1 K (+8.69 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Rowena | CHIEF OPERATING OFF ... | Buy | X | 11.25 | 35,555 | 399,994 | 71,110 | 35.6 K to 71.1 K (+100.00 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Option Exercise | X | 0.00 | 35,555 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Option Exercise | X | 0.00 | 38,055 | 0 | 0 | |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Buy | X | 11.25 | 35,555 | 399,994 | 71,110 | 35.6 K to 71.1 K (+100.00 %) |
| Jul 31 2020 | ADTX | ADiTx Therapeutics ... | Albanna Amro A. | CHIEF EXECUTIVE OFF ... | Buy | X | 11.25 | 38,055 | 428,119 | 476,110 | 438.1 K to 476.1 K (+8.69 %) |
Page: 1